1.
Silverberg J, Bieber T, Paller A, Beck L, Kamata M, Puig L, Wiseman M, Ezzedine K, Foley P, Johansson E, Dossenbach M, Akmaz B, Casillas M, Karlsson A, Chovatiya R. Efficacy Comparison of Targeted Systemic Monotherapies Including Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: a Network Meta-Analysis. J of Skin [Internet]. 2024Jan.16 [cited 2024Jul.22];8(1):s313. Available from: https://jofskin.org/index.php/skin/article/view/2391